Company / Operating Income per Share
Beta Bionics, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$10.75
FY2025
5-year range
-$10.75 / -$6.76
FY2023-FY2025
Trend
-26.0%
vs FY2024
Sector context
#151 of 154
Health Care
What the data says
Among 154 Health Care companies, Beta Bionics, Inc. is in the bottom 2% for operating income per share. Declined from $-6.76 to $-10.75 over the past 2 years.
Based on SEC 10-K filings.
-10.75 in FY2025.
Declined from $-6.76 to $-10.75 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 154This company -$10.75 Sector average $4.29
▼
-350.8% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 26.0% year-over-year.
- Ranks #151 out of 154 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.75 | -26.0% |
| FY2024 | -$8.53 | -26.2% |
| FY2023 | -$6.76 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026